Search results
Results will auto-populate based on filter selection.
963
Found 963 result(s)
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…
Corticosteroid injections in musculoskeletal conditions Indications/Clinical uses Treatment of acute and chronic musculoskeletal conditions including neck and upper…
18-04-15
Policy
If the WSIB concludes, through a non-economic loss (NEL) determination, see 18-05-03, Determining…
18-04-09
Policy
A worker may elect to receive an amount equal to the full monthly pension for Old Age Security (OAS), instead of a future economic loss (FEL) benefit, if the worker…
Toronto, May 19, 2020 – The WSIB is pleased to announce that Elizabeth Witmer has been reappointed Chair of the Board of Directors of Ontario’s WSIB for a third term. …
Toronto, November 25, 2020 - The WSIB is pleased to announce that Elizabeth Witmer has been reappointed Chair of the Board of Directors of Ontario’s WSIB for a fourth term…
12-04-03
Policy
An authority who summons a person to assist in controlling or extinguishing a fire is deemed the person's employer.
The Crown is deemed the employer of a person who…
12-01-02
Law
s.74(1)
Upon application, the WSIB may declare an employer to be deemed a Schedule 1 employer for purposes of the insurance plan.
Policy
An employer may apply for…